Statins in Coronary Bypass Surgery

Rationale and Clinical Use

José Pablo Werba, Elena Tremoli, Paola Massironi, Marina Camera, Aldo Cannata, Francesco Alamanni, Paolo Biglioli, Alessandro Parolari

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Statin therapy prevents the first occurrence and recurrence of coronary events and reduces cardiovascular and general mortality in patients with coronary artery disease. These compounds modulate a variety of processes involved in the pathophysiology of arteriosclerosis and vascular graft disease by lipid-dependent and lipid-independent (pleiotropic) mechanisms. As a result, statins produce angiographic and clinical benefits in patients undergoing coronary bypass surgery. We review the present knowledge about the effects of statins on this pathologic condition and the evidence supporting an early treatment initiation.

Original languageEnglish
Pages (from-to)2132-2140
Number of pages9
JournalAnnals of Thoracic Surgery
Volume76
Issue number6
DOIs
Publication statusPublished - Dec 2003

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids
Arteriosclerosis
Vascular Diseases
Coronary Artery Disease
Transplants
Recurrence
Mortality
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Statins in Coronary Bypass Surgery : Rationale and Clinical Use. / Werba, José Pablo; Tremoli, Elena; Massironi, Paola; Camera, Marina; Cannata, Aldo; Alamanni, Francesco; Biglioli, Paolo; Parolari, Alessandro.

In: Annals of Thoracic Surgery, Vol. 76, No. 6, 12.2003, p. 2132-2140.

Research output: Contribution to journalArticle

@article{e878f9dc1cd5405b855b0f56acd71762,
title = "Statins in Coronary Bypass Surgery: Rationale and Clinical Use",
abstract = "Statin therapy prevents the first occurrence and recurrence of coronary events and reduces cardiovascular and general mortality in patients with coronary artery disease. These compounds modulate a variety of processes involved in the pathophysiology of arteriosclerosis and vascular graft disease by lipid-dependent and lipid-independent (pleiotropic) mechanisms. As a result, statins produce angiographic and clinical benefits in patients undergoing coronary bypass surgery. We review the present knowledge about the effects of statins on this pathologic condition and the evidence supporting an early treatment initiation.",
author = "Werba, {Jos{\'e} Pablo} and Elena Tremoli and Paola Massironi and Marina Camera and Aldo Cannata and Francesco Alamanni and Paolo Biglioli and Alessandro Parolari",
year = "2003",
month = "12",
doi = "10.1016/S0003-4975(03)00820-8",
language = "English",
volume = "76",
pages = "2132--2140",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "The Society of Thoracic Surgeons. Published by Elsevier Inc",
number = "6",

}

TY - JOUR

T1 - Statins in Coronary Bypass Surgery

T2 - Rationale and Clinical Use

AU - Werba, José Pablo

AU - Tremoli, Elena

AU - Massironi, Paola

AU - Camera, Marina

AU - Cannata, Aldo

AU - Alamanni, Francesco

AU - Biglioli, Paolo

AU - Parolari, Alessandro

PY - 2003/12

Y1 - 2003/12

N2 - Statin therapy prevents the first occurrence and recurrence of coronary events and reduces cardiovascular and general mortality in patients with coronary artery disease. These compounds modulate a variety of processes involved in the pathophysiology of arteriosclerosis and vascular graft disease by lipid-dependent and lipid-independent (pleiotropic) mechanisms. As a result, statins produce angiographic and clinical benefits in patients undergoing coronary bypass surgery. We review the present knowledge about the effects of statins on this pathologic condition and the evidence supporting an early treatment initiation.

AB - Statin therapy prevents the first occurrence and recurrence of coronary events and reduces cardiovascular and general mortality in patients with coronary artery disease. These compounds modulate a variety of processes involved in the pathophysiology of arteriosclerosis and vascular graft disease by lipid-dependent and lipid-independent (pleiotropic) mechanisms. As a result, statins produce angiographic and clinical benefits in patients undergoing coronary bypass surgery. We review the present knowledge about the effects of statins on this pathologic condition and the evidence supporting an early treatment initiation.

UR - http://www.scopus.com/inward/record.url?scp=0345527039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345527039&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(03)00820-8

DO - 10.1016/S0003-4975(03)00820-8

M3 - Article

VL - 76

SP - 2132

EP - 2140

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -